Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AvantSleep is a Canadian healthcare company dedicated to the diagnosis and treatment of sleep-disordered breathing, with a primary focus on obstructive sleep apnea (OSA). The company operates a network of clinics across Canada, providing patients with home sleep apnea testing (HSAT) and Continuous Positive Airway Pressure (CPAP) therapy solutions. Their service model emphasizes long-term clinical support and patient education to ensure high therapy compliance and improved health outcomes. AvantSleep streamlines the transition from initial screening to chronic disease management through integrated diagnostic and therapeutic pathways. In 2018, the company was acquired by VitalAire Canada, a subsidiary of Air Liquide, expanding the parent company's reach in the Canadian respiratory homecare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AvantSleep.